Zotatifin clinical trials
Also written eFT226.
How each study uses zotatifin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the zotatifin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2019 (1); 1 more planned to start later
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
Effector Therapeutics (2) · Jennifer Lee Caswell-Jin (1) · M.D. Anderson Cancer Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses zotatifin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBCNot yet recruitingPhase 1M.D. Anderson Cancer CenterNCT07783659Written as Zotatifin
- Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesRecruitingPhase 1/2Effector TherapeuticsNCT04092673Written as eFT226
- Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast CancerCompletedPhase 2Jennifer Lee Caswell-JinNCT05101564Written as Zotatifin
- Intravenous Zotatifin in Adults With Mild or Moderate COVID-19CompletedPhase 1Effector TherapeuticsNCT04632381Written as Zotatifin
Codes
What other systems call zotatifin · ClinicalTrials.gg INT014468
- UNII (FDA) 2EWN8Z05CNZOTATIFINOne source FDA
- NCI Thesaurus C165746ZotatifinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2EWN8Z05CN | ZOTATIFIN | One source FDA |
| NCI Thesaurus | C165746 | Zotatifin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.